Conditions: CPC · tirzepatide.
The figures are clear enough; the question is what they mean and what they do not.
I can supply the numbers if the specifics change the answer.
What would I need in addition before this supported a decision?
The part that matters: the most common trap is reading a certificate as if it were a guarantee when it is actually a single point estimate from a single test.
The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.
| Component | Typical share | Counted in purity? | Counted in content? |
|---|---|---|---|
| Target peptide | 88–94 % | Yes, as main peak | Yes |
| Related impurities | 1–3 % | Yes, as other peaks | No |
| Counter-ion (TFA or acetate) | 2–8 % | No | No |
| Residual water | 2–6 % | No | No |
| Bulking agent, if present | 0–40 % | No | No |
Put another way, comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.
If the certificate does not trace to your vial, it is not evidence about your vial.
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsWhat a useful certificate carries is debatable, but there are certain fields that almost no research-grade certificate includes despite their being standard in pharmaceutical work.
Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.
The relevant detail is that multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
More usefully, reading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.
The laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.
A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
My working rule is that a document without a lot number, a method section and a test date is marketing.
edited 4 May 2025 by mz_4113 — added a caveat about sampling
The underlying point is that what makes a certificate useful is not its appearance but whether you could hand it to another laboratory and they would reproduce the result.
A purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.
Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.
If the certificate does not trace to your vial, it is not evidence about your vial.
To be exact about it, a certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.